{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T19:13:01Z","timestamp":1793041981458,"version":"4.5.0"},"reference-count":124,"publisher":"Elsevier BV","issue":"13","license":[{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,9,30]],"date-time":"2015-09-30T00:00:00Z","timestamp":1443571200000},"content-version":"vor","delay-in-days":394,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1016\/j.jacc.2014.04.083","type":"journal-article","created":{"date-parts":[[2014,9,22]],"date-time":"2014-09-22T15:45:18Z","timestamp":1411400718000},"page":"1388-1400","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":220,"title":["Metabolic Impairment in Heart Failure"],"prefix":"10.1016","volume":"64","author":[{"given":"Wolfram","family":"Doehner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Frenneaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan D.","family":"Anker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2014.04.083_bib1","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.jacc.2008.03.061","article-title":"Heart failure-related hospitalization in the U.S., 1979 to 2004","volume":"52","author":"Fang","year":"2008","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2014.04.083_bib2","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1161\/CIRCULATIONAHA.105.605980","article-title":"Reduced peripheral skeletal muscle mass and abnormal reflex physiology in chronic heart failure","volume":"114","author":"Piepoli","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2014.04.083_bib3","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1097\/MED.0b013e3283469505","article-title":"Hormonal consequences and prognosis of chronic heart failure","volume":"18","author":"Attanasio","year":"2011","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"10.1016\/j.jacc.2014.04.083_bib4","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.cardiores.2006.08.018","article-title":"Nutrition, metabolism and the complex pathophysiology of cachexia in chronic heart failure","volume":"73","author":"von Haehling","year":"2007","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jacc.2014.04.083_bib5","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1161\/01.CIR.96.2.526","article-title":"Hormonal changes and catabolic\/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia","volume":"96","author":"Anker","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2014.04.083_bib6","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1161\/CIRCULATIONAHA.106.649426","article-title":"Anabolic deficiency in men with chronic heart failure: prevalence and detrimental impact on survival","volume":"114","author":"Jankowska","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2014.04.083_bib7","doi-asserted-by":"crossref","first-page":"19229","DOI":"10.1074\/jbc.M801331200","article-title":"Insulin signaling and the general amino acid control response. Two distinct pathways to amino acid synthesis and uptake","volume":"283","author":"Malmberg","year":"2008","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jacc.2014.04.083_bib8","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1042\/CS20100110","article-title":"Impaired muscle protein anabolic response to insulin and amino acids in heart failure patients: relationship with markers of immune activation","volume":"119","author":"Toth","year":"2010","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.jacc.2014.04.083_bib9","doi-asserted-by":"crossref","first-page":"4160","DOI":"10.1210\/en.2006-0251","article-title":"Insulin resistance accelerates muscle protein degradation: activation of the ubiquitin-proteasome pathway by defects in muscle cell signaling","volume":"147","author":"Wang","year":"2006","journal-title":"Endocrinology"},{"key":"10.1016\/j.jacc.2014.04.083_bib10","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0735-1097(97)00185-X","article-title":"Insulin resistance in chronic heart failure: relation to severity and etiology of heart failure","volume":"30","author":"Swan","year":"1997","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2014.04.083_bib11","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.jacc.2005.02.093","article-title":"Impaired insulin sensitivity as an independent risk factor for mortality in patients with stable chronic heart failure","volume":"46","author":"Doehner","year":"2005","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2014.04.083_bib12","doi-asserted-by":"crossref","first-page":"269","DOI":"10.2165\/00129784-200404050-00001","article-title":"Impaired glucose metabolism in patients with heart failure: pathophysiology and possible treatment strategies","volume":"4","author":"Tenenbaum","year":"2004","journal-title":"Am J Cardiovasc Drugs"},{"key":"10.1016\/j.jacc.2014.04.083_bib13","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0167-5273(02)00022-0","article-title":"Insulin resistance in moderate chronic heart failure is related to hyperleptinaemia, but not to norepinephrine or TNF-alpha","volume":"83","author":"Doehner","year":"2002","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2014.04.083_bib14","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1530\/eje.0.1450727","article-title":"Leptin, insulin sensitivity and growth hormone binding protein in chronic heart failure with and without cardiac cachexia","volume":"145","author":"Doehner","year":"2001","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.jacc.2014.04.083_bib15","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0735-1097(01)01385-7","article-title":"Acquired growth hormone resistance in patients with chronic heart failure: implications for therapy with growth hormone","volume":"38","author":"Anker","year":"2001","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2014.04.083_bib16","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/S0140-6736(97)11329-0","article-title":"Randomised, double blind, placebo-controlled trial of human recombinant growth hormone in patients with chronic heart failure due to dilated cardiomyopathy","volume":"351","author":"Osterziel","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2014.04.083_bib17","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.cardfail.2008.12.011","article-title":"Reduction in circulating testosterone relates to exercise capacity in men with chronic heart failure","volume":"15","author":"Jankowska","year":"2009","journal-title":"J\u00a0Card Fail"},{"key":"10.1016\/j.jacc.2014.04.083_bib18","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1161\/hc4201.097836","article-title":"Elevated circulating level of ghrelin in cachexia associated with chronic heart failure: relationships between ghrelin and anabolic\/catabolic factors","volume":"104","author":"Nagaya","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2014.04.083_bib19","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.jacc.2008.07.073","article-title":"Resistin, adiponectin, and risk of heart failure the Framingham offspring study","volume":"53","author":"Frankel","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2014.04.083_bib20","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.numecd.2013.04.015","article-title":"Plasma adiponectin in heart failure with and without cachexia: catabolic signal linking catabolism, symptomatic status, and prognosis","volume":"24","author":"Szab\u00f3","year":"2014","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.jacc.2014.04.083_bib21","doi-asserted-by":"crossref","first-page":"3622","DOI":"10.1210\/jc.2004-1953","article-title":"Lipid mobilization with physiological atrial natriuretic peptide concentrations in humans","volume":"90","author":"Birkenfeld","year":"2005","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.jacc.2014.04.083_bib22","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/j.jacc.2007.07.016","article-title":"Altered intestinal function in patients with chronic heart failure","volume":"50","author":"Sandek","year":"2007","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2014.04.083_bib23","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1139\/H09-013","article-title":"Exercise training, energy metabolism, and heart failure","volume":"34","author":"Ventura-Clapier","year":"2009","journal-title":"Appl Physiol Nutr Metab"},{"key":"10.1016\/j.jacc.2014.04.083_bib24","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.yjmcc.2008.03.021","article-title":"The PPAR trio: regulators of myocardial energy metabolism in health and disease","volume":"44","author":"Madrazo","year":"2008","journal-title":"J\u00a0Mol Cell Cardiol"},{"key":"10.1016\/j.jacc.2014.04.083_bib25","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s00395-003-0411-1","article-title":"Muscular levels of proinflammatory cytokines correlate with a reduced expression of insulinlike growth factor-I in chronic heart failure","volume":"98","author":"Schulze","year":"2003","journal-title":"Basic Res Cardiol"},{"key":"10.1016\/j.jacc.2014.04.083_bib26","first-page":"435","article-title":"Muscle wastage in chronic heart failure, between apoptosis, catabolism and altered anabolism: a chimaeric view of inflammation?","volume":"7","author":"Libera","year":"2004","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"10.1016\/j.jacc.2014.04.083_bib27","doi-asserted-by":"crossref","first-page":"H1973","DOI":"10.1152\/ajpheart.00200.2011","article-title":"Myostatin from the heart: local and systemic actions in cardiac failure and muscle wasting","volume":"300","author":"Breitbart","year":"2011","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.jacc.2014.04.083_bib28","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/mus.20175","article-title":"Loss of myostatin expression alters fiber-type distribution and expression of myosin heavy chain isoforms in slow- and fast-type skeletal muscle","volume":"31","author":"Girgenrath","year":"2005","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jacc.2014.04.083_bib29","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ijcard.2007.07.058","article-title":"Hypothesis: myostatin is a mediator of cardiac cachexia","volume":"124","author":"Hoenig","year":"2008","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2014.04.083_bib30","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1161\/01.CIR.85.4.1364","article-title":"Contribution of skeletal muscle atrophy to exercise intolerance and altered muscle metabolism in heart failure","volume":"85","author":"Mancini","year":"1992","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2014.04.083_bib31","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1016\/S0735-1097(97)00381-1","article-title":"Skeletal muscle function and its relation to exercise tolerance in chronic heart failure","volume":"30","author":"Harrington","year":"1997","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2014.04.083_bib32","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1161\/01.RES.0000163635.62927.34","article-title":"Adipose tissue, inflammation, and cardiovascular disease","volume":"96","author":"Berg","year":"2005","journal-title":"Circ Res"},{"key":"10.1016\/j.jacc.2014.04.083_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.clnu.2006.09.009","article-title":"Fat loss in cachexia\u2014is there\u00a0a role for adipocyte lipolysis?","volume":"26","author":"Ryd\u00e9n","year":"2007","journal-title":"Clin Nutr"},{"key":"10.1016\/j.jacc.2014.04.083_bib34","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.bbrc.2004.04.010","article-title":"Targets for TNF-alpha-induced lipolysis in human adipocytes","volume":"318","author":"Ryd\u00e9n","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jacc.2014.04.083_bib35","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1096\/fasebj.14.10.1345","article-title":"Natriuretic peptides: a new lipolytic pathway in human adipocytes","volume":"14","author":"Sengen\u00e8s","year":"2000","journal-title":"FASEB J"},{"key":"10.1016\/j.jacc.2014.04.083_bib36","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.tem.2007.11.006","article-title":"Control of lipolysis by natriuretic peptides and cyclic GMP","volume":"19","author":"Lafontan","year":"2008","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.jacc.2014.04.083_bib37","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1093\/eurjhf\/hft067","article-title":"Increased catabolic activity in adipose tissue of patients with chronic heart failure","volume":"15","author":"Szab\u00f3","year":"2013","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2014.04.083_bib38","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1161\/01.RES.0000165803.47776.38","article-title":"Adipocyte signaling and lipid homeostasis: sequelae of insulin-resistant adipose tissue","volume":"96","author":"Yu","year":"2005","journal-title":"Circ Res"},{"key":"10.1016\/j.jacc.2014.04.083_bib39","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1161\/CIRCULATIONAHA.104.530972","article-title":"Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure","volume":"112","author":"Kistorp","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2014.04.083_bib40","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1093\/eurheartj\/ehm033","article-title":"Increase in serum adiponectin concentration in patients with heart failure and cachexia: relationship with leptin, other cytokines, and B-type natriuretic peptide","volume":"28","author":"McEntegart","year":"2007","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2014.04.083_bib41","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0002-9343(97)00142-3","article-title":"Bone mass, vitamin D deficiency, and hyperparathyroidism in congestive heart failure","volume":"103","author":"Shane","year":"1997","journal-title":"Am J Med"},{"key":"10.1016\/j.jacc.2014.04.083_bib42","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.archger.2008.09.004","article-title":"Osteoporosis and congestive heart failure (CHF) in the elderly patient: double disease burden","volume":"49","author":"Abou-Raya","year":"2009","journal-title":"Arch Gerontol Geriatr"},{"key":"10.1016\/j.jacc.2014.04.083_bib43","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/S0002-9149(98)00927-8","article-title":"Loss of bone mineral in patients with cachexia due to chronic heart failure","volume":"83","author":"Anker","year":"1999","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2014.04.083_bib44","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1093\/eurjhf\/hfn004","article-title":"Bone mineral status and bone loss over time in men with chronic systolic heart failure and their clinical and hormonal determinants","volume":"11","author":"Jankowska","year":"2009","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2014.04.083_bib45","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cca.2005.10.006","article-title":"Markers of bone metabolism in congestive heart failure","volume":"366","author":"Zittermann","year":"2006","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.jacc.2014.04.083_bib46","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.cardfail.2009.12.015","article-title":"Relationship between high circulating adiponectin with bone mineral density and bone metabolism in elderly males with chronic heart failure","volume":"16","author":"Bozic","year":"2010","journal-title":"J\u00a0Card Fail"},{"key":"10.1016\/j.jacc.2014.04.083_bib47","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0167-5273(02)00230-9","article-title":"Cardiac cachexia in early literature: a review of research prior to Medline","volume":"85","author":"Doehner","year":"2002","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2014.04.083_bib48","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/S0140-6736(96)07015-8","article-title":"Wasting as independent risk factor for mortality in chronic heart failure","volume":"349","author":"Anker","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2014.04.083_bib49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13539-010-0002-6","article-title":"Cachexia as a major underestimated and unmet medical need: facts and numbers","volume":"1","author":"von Haehling","year":"2010","journal-title":"J\u00a0Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.jacc.2014.04.083_bib50","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.clnu.2009.12.004","article-title":"Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by Special Interest Groups (SIG) \u201ccachexia-anorexia in chronic wasting diseases\u201d and \u201cnutrition in geriatrics.\u201d","volume":"29","author":"Muscaritoli","year":"2010","journal-title":"Clin Nutr"},{"key":"10.1016\/j.jacc.2014.04.083_bib51","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/S0140-6736(03)12892-9","article-title":"Prognostic importance of weight loss in chronic heart\u00a0failure and the effect of treatment with\u00a0angiotensin-converting-enzyme inhibitors: an observational study","volume":"361","author":"Anker","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2014.04.083_bib52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13539-012-0059-5","article-title":"The obesity paradox in chronic disease: facts and\u00a0numbers","volume":"3","author":"Lainscak","year":"2012","journal-title":"J\u00a0Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.jacc.2014.04.083_bib53","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.clnu.2008.06.013","article-title":"Cachexia: a new definition","volume":"27","author":"Evans","year":"2008","journal-title":"Clin Nutr"},{"key":"10.1016\/j.jacc.2014.04.083_bib54","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1016\/j.jacc.2006.08.034","article-title":"Etiology of anemia in patients with advanced heart failure","volume":"48","author":"Nanas","year":"2006","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2014.04.083_bib55","doi-asserted-by":"crossref","first-page":"5277","DOI":"10.1182\/blood-2008-12-195651","article-title":"Regulation of iron homeostasis in anemia of chronic disease and iron deficiency anemia: diagnostic and therapeutic implications","volume":"113","author":"Theurl","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.jacc.2014.04.083_bib56","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.cell.2010.06.028","article-title":"Two to tango: regulation of Mammalian iron metabolism","volume":"142","author":"Hentze","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.jacc.2014.04.083_bib57","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1172\/JCI200420945","article-title":"IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin","volume":"113","author":"Nemeth","year":"2004","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jacc.2014.04.083_bib58","doi-asserted-by":"crossref","first-page":"3593","DOI":"10.1182\/blood-2008-08-173641","article-title":"Contribution of STAT3 and SMAD4 pathways to the regulation of hepcidin by opposing stimuli","volume":"113","author":"Huang","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.jacc.2014.04.083_bib59","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1161\/01.CIR.0000052622.51963.FC","article-title":"Anemia is common in heart failure and is associated with poor outcomes: insights from a cohort of 12 065 patients with new-onset heart failure","volume":"107","author":"Ezekowitz","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2014.04.083_bib60","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1056\/NEJMra041809","article-title":"Anemia of chronic disease","volume":"352","author":"Weiss","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2014.04.083_bib61","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1056\/NEJMoa0908355","article-title":"Ferric carboxymaltose in patients with heart failure and iron deficiency","volume":"361","author":"Anker","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2014.04.083_bib62","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.cardfail.2011.08.003","article-title":"Iron deficiency predicts impaired exercise capacity in patients with systolic chronic heart failure","volume":"17","author":"Jankowska","year":"2011","journal-title":"J\u00a0Card Fail"},{"key":"10.1016\/j.jacc.2014.04.083_bib63","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1146\/annurev.cellbio.22.010305.104538","article-title":"Iron\u2013sulfur protein biogenesis in eukaryotes: components and mechanisms","volume":"22","author":"Lill","year":"2006","journal-title":"Annu Rev Cell Dev Biol"},{"key":"10.1016\/j.jacc.2014.04.083_bib64","doi-asserted-by":"crossref","first-page":"3003","DOI":"10.1089\/ars.2011.3921","article-title":"Mitochondrial mayhem: the mitochondrion as a modulator of iron metabolism and its role in disease","volume":"15","author":"Huang","year":"2011","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.jacc.2014.04.083_bib65","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1067\/mhj.2001.114367","article-title":"Uric acid in cachectic and non-cachectic patients with chronic heart failure: relationship to leg vascular resistance","volume":"141","author":"Doehner","year":"2001","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2014.04.083_bib66","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1161\/01.CIR.0000065637.10517.A0","article-title":"Uric acid and survival in chronic heart failure: validation and application in metabolic, functional, and hemodynamic staging","volume":"107","author":"Anker","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2014.04.083_bib67","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1161\/CIRCULATIONAHA.105.584102","article-title":"The Seattle Heart Failure Model: prediction of survival in heart failure","volume":"113","author":"Levy","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2014.04.083_bib68","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1016\/S0026-0495(98)90293-1","article-title":"Uric acid in chronic heart failure: a measure of the anaerobic threshold","volume":"47","author":"Leyva","year":"1998","journal-title":"Metabolism"},{"key":"10.1016\/j.jacc.2014.04.083_bib69","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0026-0495(98)90026-9","article-title":"The glycolytic pathway to coronary heart disease: a hypothesis","volume":"47","author":"Leyva","year":"1998","journal-title":"Metabolism"},{"key":"10.1016\/j.jacc.2014.04.083_bib70","first-page":"193","article-title":"Subcellular distribution of xanthine oxidase during cardiac ischemia and\u00a0reperfusion: an immunocytochemical study","volume":"25","author":"Ashraf","year":"1993","journal-title":"J\u00a0Submicrosc Cytol Pathol"},{"key":"10.1016\/j.jacc.2014.04.083_bib71","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.semnephrol.2011.08.007","article-title":"Xanthine oxidase and uric acid in cardiovascular disease: clinical impact and therapeutic options","volume":"31","author":"Doehner","year":"2011","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.jacc.2014.04.083_bib72","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.ijcard.2006.05.003","article-title":"Uric acid in CHF: marker or player in a metabolic disease?","volume":"115","author":"Doehner","year":"2007","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2014.04.083_bib73","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1161\/CIRCHEARTFAILURE.109.868604","article-title":"Uric acid-lowering treatment with benzbromarone in patients with heart failure: a double blind placebo-controlled cross-over preliminary study","volume":"3","author":"Ogino","year":"2010","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jacc.2014.04.083_bib74","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.1007\/s00125-007-0817-7","article-title":"Lowering serum urate does not improve endothelial function in patients with type 2 diabetes","volume":"50","author":"Waring","year":"2007","journal-title":"Diabetologia"},{"key":"10.1016\/j.jacc.2014.04.083_bib75","doi-asserted-by":"crossref","first-page":"H1345","DOI":"10.1152\/ajpheart.2000.278.4.H1345","article-title":"Myocardial substrate metabolism influences left ventricular energetics in\u00a0vivo","volume":"278","author":"Korvald","year":"2000","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.jacc.2014.04.083_bib76","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1016\/0735-1097(94)90665-3","article-title":"Improved hemodynamic function and mechanical efficiency in congestive heart failure with sodium dichloroacetate","volume":"23","author":"Bersin","year":"1994","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2014.04.083_bib77","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1161\/CIRCULATIONAHA.106.645184","article-title":"Free fatty acid depletion acutely decreases cardiac work and efficiency in cardiomyopathic heart failure","volume":"114","author":"Tuunanen","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2014.04.083_bib78","doi-asserted-by":"crossref","first-page":"H1096","DOI":"10.1152\/ajpheart.00930.2009","article-title":"Cardiovascular and metabolic effects of 48-h glucagon-like peptide-1 infusion in compensated chronic patients with heart failure","volume":"298","author":"Halbirk","year":"2010","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.jacc.2014.04.083_bib79","doi-asserted-by":"crossref","first-page":"H2304","DOI":"10.1152\/ajpheart.00599.2005","article-title":"Malonyl-CoA decarboxylase inhibition suppresses fatty acid oxidation and reduces lactate production during demand-induced ischemia","volume":"289","author":"Stanley","year":"2005","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.jacc.2014.04.083_bib80","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/0006-2952(96)00204-3","article-title":"Inhibition of carnitine palmitoyltransferase-1 in rat heart and liver by perhexiline and amiodarone","volume":"52","author":"Kennedy","year":"1996","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.jacc.2014.04.083_bib81","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.cardiores.2005.02.004","article-title":"Carnitine palmitoyl transferase-I inhibition prevents ventricular remodeling and delays decompensation in pacing-induced heart failure","volume":"66","author":"Lionetti","year":"2005","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jacc.2014.04.083_bib82","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s00395-009-0015-5","article-title":"The metabolic modulators, Etomoxir and NVP-LAB121, fail to reverse pressure overload induced heart failure in\u00a0vivo","volume":"104","author":"Schwarzer","year":"2009","journal-title":"Basic Res Cardiol"},{"key":"10.1016\/j.jacc.2014.04.083_bib83","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1042\/cs0990027","article-title":"First clinical trial with etomoxir in patients with chronic congestive heart failure","volume":"99","author":"Schmidt-Schweda","year":"2000","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.jacc.2014.04.083_bib84","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1042\/CS20060307","article-title":"A\u00a0double-blind randomized multicentre clinical trial to evaluate the efficacy and safety of two doses of etomoxir in comparison with placebo in patients with moderate congestive heart failure: the ERGO (etomoxir for the recovery of glucose) study","volume":"113","author":"Holubarsch","year":"2007","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.jacc.2014.04.083_bib85","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0167-5273(86)90146-4","article-title":"Perhexiline maleate treatment for severe angina pectoris\u2013correlations with pharmacokinetics","volume":"13","author":"Horowitz","year":"1986","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2014.04.083_bib86","doi-asserted-by":"crossref","first-page":"3280","DOI":"10.1161\/CIRCULATIONAHA.105.551457","article-title":"Metabolic modulation with perhexiline in chronic heart failure: a randomized, controlled trial of short-term use of a novel treatment","volume":"112","author":"Lee","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2014.04.083_bib87","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1161\/CIRCULATIONAHA.109.934059","article-title":"Metabolic modulator perhexiline corrects energy deficiency and improves exercise capacity in symptomatic hypertrophic cardiomyopathy","volume":"122","author":"Abozguia","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2014.04.083_bib88","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ejphar.2005.11.058","article-title":"Effect of the anti-anginal agent, perhexiline, on neutrophil, valvular and vascular superoxide formation","volume":"531","author":"Kennedy","year":"2006","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jacc.2014.04.083_bib89","first-page":"A14461","article-title":"How does perhexiline modulate myocardial energetics and ameliorate redox stress (abstr)?","volume":"124","author":"Ngo","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2014.04.083_bib90","doi-asserted-by":"crossref","first-page":"e7124","DOI":"10.1371\/journal.pone.0007124","article-title":"Screen for chemical modulators of autophagy reveals novel therapeutic inhibitors of mTORC1 signaling","volume":"4","author":"Balgi","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.jacc.2014.04.083_bib91","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S1071-9164(98)90252-4","article-title":"Beta-receptor blockade decreases carnitine palmitoyl transferase I activity in dogs with heart failure","volume":"4","author":"Panchal","year":"1998","journal-title":"J\u00a0Card Fail"},{"key":"10.1016\/j.jacc.2014.04.083_bib92","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1161\/01.CIR.103.20.2441","article-title":"Myocardial free fatty acid and glucose use after carvedilol treatment in patients with congestive heart failure","volume":"103","author":"Wallhaus","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2014.04.083_bib93","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1016\/S0022-2828(95)90524-3","article-title":"Effect of sulfo-N-succinimidyl palmitate on the rat heart: myocardial long-chain fatty acid uptake and cardiac hypertrophy","volume":"27","author":"Kusaka","year":"1995","journal-title":"J\u00a0Mol Cell Cardiol"},{"key":"10.1016\/j.jacc.2014.04.083_bib94","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1161\/01.RES.86.5.580","article-title":"The antianginal drug trimetazidine shifts cardiac energy metabolism from fatty acid oxidation to glucose oxidation by inhibiting mitochondrial long-chain 3-ketoacyl coenzyme A thiolase","volume":"86","author":"Kantor","year":"2000","journal-title":"Circ Res"},{"key":"10.1016\/j.jacc.2014.04.083_bib95","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1161\/CIRCULATIONAHA.108.778019","article-title":"Trimetazidine, a metabolic modulator, has cardiac and extracardiac benefits in idiopathic dilated cardiomyopathy","volume":"118","author":"Tuunanen","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2014.04.083_bib96","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.jacc.2011.11.027","article-title":"Additional use of\u00a0trimetazidine in patients with chronic heart failure: a meta-analysis","volume":"59","author":"Zhang","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2014.04.083_bib97","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1093\/eurheartj\/ehi816","article-title":"Effects of metabolic modulation by trimetazidine on left ventricular function and phosphocreatine\/adenosine triphosphate ratio in patients with heart failure","volume":"27","author":"Fragasso","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2014.04.083_bib98","doi-asserted-by":"crossref","first-page":"E865","DOI":"10.1016\/S0735-1097(12)60866-3","article-title":"Ranolazine for the treatment of diastolic heart failure in patients with preserved ejection fraction: results from the RALI-DHF study (abstr)","volume":"59","author":"Maier","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2014.04.083_bib99","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1016\/S0140-6736(09)60953-3","article-title":"Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised open-label trial","volume":"373","author":"Home","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2014.04.083_bib100","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ijcard.2011.09.039","article-title":"Inverse relation of body weight and weight change with mortality and morbidity in patients with type 2 diabetes and cardiovascular co-morbidity: an analysis of the PROactive study population","volume":"162","author":"Doehner","year":"2012","journal-title":"Int J\u00a0Cardiol"},{"key":"10.1016\/j.jacc.2014.04.083_bib101","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1161\/01.CIR.0000154542.13412.B1","article-title":"Thiazolidinediones, metformin, and outcomes in older patients with diabetes and heart failure: an observational study","volume":"111","author":"Masoudi","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2014.04.083_bib102","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1093\/eurjhf\/hfs106","article-title":"The effect of metformin on insulin resistance and exercise parameters in patients with heart failure","volume":"14","author":"Wong","year":"2012","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2014.04.083_bib103","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S0953-6205(02)00131-0","article-title":"Metformin in patients with type 2 diabetes mellitus: reconsideration of traditional contraindications","volume":"13","author":"Rachmani","year":"2002","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.jacc.2014.04.083_bib104","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.ijcard.2011.10.141","article-title":"Metformin therapy and prognosis of patients with heart failure and new-onset diabetes mellitus. A propensity-matched study in the community","volume":"166","author":"Romero","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2014.04.083_bib105","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1056\/NEJMoa1307684","article-title":"Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus","volume":"369","author":"Scirica","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2014.04.083_bib106","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1111\/dom.12126","article-title":"Are users of sulphonylureas at the time of an acute coronary syndrome at risk of poorer outcomes?","volume":"15","author":"Nagendran","year":"2013","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.jacc.2014.04.083_bib107","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1126\/science.1106653","article-title":"Extension of murine life span by overexpression of catalase targeted to mitochondria","volume":"308","author":"Schriner","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.jacc.2014.04.083_bib108","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.1161\/CIRCULATIONAHA.108.822403","article-title":"Overexpression of catalase targeted to mitochondria attenuates murine cardiac aging","volume":"119","author":"Dai","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2014.04.083_bib109","doi-asserted-by":"crossref","first-page":"34682","DOI":"10.1074\/jbc.M402999200","article-title":"Cell-permeable peptide antioxidants targeted to inner mitochondrial membrane inhibit mitochondrial swelling, oxidative cell death, and reperfusion injury","volume":"279","author":"Zhao","year":"2004","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jacc.2014.04.083_bib110","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jacc.2010.12.044","article-title":"Mitochondrial targeted antioxidant peptide ameliorates hypertensive cardiomyopathy","volume":"58","author":"Dai","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2014.04.083_bib111","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1111\/acel.12102","article-title":"Mitochondrial-targeted peptide rapidly improves mitochondrial energetics and skeletal muscle performance in aged mice","volume":"12","author":"Siegel","year":"2013","journal-title":"Aging Cell"},{"key":"10.1016\/j.jacc.2014.04.083_bib112","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1161\/CIRCHEARTFAILURE.113.000406","article-title":"Global proteomics and pathway analysis of pressure-overload-induced heart failure and its attenuation by mitochondrial-targeted peptides","volume":"6","author":"Dai","year":"2013","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jacc.2014.04.083_bib113","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0006-291X(05)80137-8","article-title":"Therapy with coenzyme Q10 of patients in heart failure who are eligible or ineligible for a transplant","volume":"182","author":"Folkers","year":"1992","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jacc.2014.04.083_bib114","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.cardfail.2006.03.007","article-title":"The impact of coenzyme Q10 on systolic function in patients with chronic heart failure","volume":"12","author":"Sander","year":"2006","journal-title":"J\u00a0Card Fail"},{"key":"10.1016\/j.jacc.2014.04.083_bib115","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.jacc.2011.10.895","article-title":"Allopurinol acutely increases adenosine triphospate energy delivery in failing human hearts","volume":"59","author":"Hirsch","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2014.04.083_bib116","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1136\/hrt.2004.057190","article-title":"Xanthine oxidase inhibition for chronic heart failure: is allopurinol the next therapeutic advance in heart failure?","volume":"91","author":"Doehner","year":"2005","journal-title":"Heart"},{"key":"10.1016\/j.jacc.2014.04.083_bib117","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1111\/j.1742-1241.2009.02118.x","article-title":"Association between allopurinol and mortality in heart failure patients: a long-term follow-up study","volume":"63","author":"Wei","year":"2009","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.jacc.2014.04.083_bib118","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1016\/j.jacc.2008.01.068","article-title":"Impact of oxypurinol in patients with symptomatic heart failure. Results of the OPT-CHF study","volume":"51","author":"Hare","year":"2008","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2014.04.083_bib119","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1002\/clc.4960190905","article-title":"Hemodynamic effects of creatine phosphate in patients with congestive heart failure: a double-blind comparison trial versus placebo","volume":"19","author":"Ferraro","year":"1996","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.jacc.2014.04.083_bib120","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/clc.20846","article-title":"Coenzyme Q10 terclatrate and creatine in chronic heart failure: a randomized, placebo-controlled, double-blind study","volume":"34","author":"Fumagalli","year":"2011","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.jacc.2014.04.083_bib121","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1253\/jcj.54.12_1471","article-title":"Myocardial free carnitine and fatty acylcarnitine levels in patients with chronic heart failure","volume":"54","author":"Masumura","year":"1990","journal-title":"Jpn Circ J"},{"key":"10.1016\/j.jacc.2014.04.083_bib122","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.mayocp.2013.02.007","article-title":"L-carnitine in the secondary prevention of cardiovascular disease: systematic review and meta-analysis","volume":"88","author":"DiNicolantonio","year":"2013","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jacc.2014.04.083_bib123","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1093\/eurheartj\/ehi443","article-title":"Testosterone therapy in men with moderate severity heart failure: a double-blind randomized placebo controlled trial","volume":"27","author":"Malkin","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2014.04.083_bib124","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1093\/eurjhf\/hfs105","article-title":"ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012","volume":"14","author":"McMurray","year":"2012","journal-title":"Eur J Heart Fail"}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109714054771?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109714054771?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T13:07:01Z","timestamp":1760015221000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109714054771"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":124,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["S0735109714054771"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2014.04.083","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2014,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabolic Impairment in Heart Failure","name":"articletitle","label":"Article Title"},{"value":"Journal of the American College of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2014.04.083","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 American College of Cardiology\u00a0Foundation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}